Because of higher average costs (a¼US$3.5) and lower incidence, cholera programs are less attractive. A program targeting both groups of children, and perhaps even programs that included adults, would probably pass a cost-benefit test. Cost-effectiveness ratios are worse than for typhoid, so the argument for allocating public subsidies to cholera vaccination is even weaker. A financially-sustainable program with user fees of a¼US$3.5 is possible. Although only 16% of the population would be vaccinated, the program (with herd effects) would still avoid 329 cases over 3 years.MacPherson and Tonkin (1992) used a decision analysis framework to evaluate the cost-effectiveness of vaccinating North Americans traveling to cholera endemic areas. ... They did not attempt to quantify the public sector or private/ social 32 Because vaccine costs include the cost to ... HIV/AIDS Uganda Respondent CV (Referendum (2004) price) Suraratdecha et HIV/AIDS Thailand ( eight Respondentanbsp;...
|Title||:||Are Cholera and Typhoid Vaccines a Good Investment for a Slum in Kolkata, India?|
|Author||:||Joseph H. Cook|
|Publisher||:||ProQuest - 2007|